From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)
 | Tofacitinib N=72 | PBO N=70 | p value | Tofacitinib N=72 | PBO N=70 | p value |
---|---|---|---|---|---|---|
 | cJADAS10 LDA | JADAS10-CRP LDA | ||||
W18 | 34 (47.2) | 32 (45.7) | 0.857 | 35 (48.6) | 33 (47.1) | 0.861 |
W24 | 32 (44.4) | 21 (30.0) | 0.072 | 34 (47.2) | 24 (34.3) | 0.114 |
W44 | 34 (47.2) | 22 (31.4) | 0.051 | 34 (47.2) | 23 (32.9) | 0.077 |
 | cJADAS10 LDA + normal function | JADAS10-CRP LDA + normal function | ||||
W18 | 17 (23.6) | 20 (28.6) | 0.501 | 17 (23.6) | 20 (28.6) | 0.501 |
W24 | 23 (32.0) | 14 (20.0) | 0.101 | 24 (33.3) | 15 (21.4) | 0.108 |
W44 | 26 (36.1) | 13 (18.6) | 0.017 | 25 (34.7) | 14 (20.0) | 0.046 |